Skip to main content
. 2017 Oct 24;8(1):2045893217741429. doi: 10.1177/2045893217741429

Fig. 12.

Fig. 12.

Confirmation of the PASMC and PAEC phenotypes using α-smooth muscle actin (SMA) and CD31 staining. (a, b) α-smooth muscle actin (SMA) immunofluorescence in control and PAH–PASMC (passage 4–6). (c, d) CD31 immunofluorescence in control and PAH–PAEC (passage 2–5).